Literature DB >> 18754694

Improved understanding of genetic and genomic influences on drug disposition and action : implications for children.

Denise Avard1, Yann Joly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18754694     DOI： 10.2165/00148581-200810050-00001

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN： 1174-5878            Impact factor:   3.022


× No keyword cloud information.
  15 in total

Review 1.  Pharmacogenomics and children: meeting the ethical challenges.

Authors:  Carol L Freund; Ellen W Clayton
Journal:  Am J Pharmacogenomics       Date:  2003

2.  Attitudes and misconceptions about predictive genetic testing for cancer risk.

Authors:  Abigail L Rose; Nikki Peters; Judy A Shea; Katrina Armstrong
Journal:  Community Genet       Date:  2005

3.  Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother.

Authors:  Gideon Koren; James Cairns; David Chitayat; Andrea Gaedigk; Steven J Leeder
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

4.  Look before you leap. Carrier screening for type 1 Gaucher disease: difficult questions.

Authors:  Pascal Borry; Angus Clarke; Kris Dierickx
Journal:  Eur J Hum Genet       Date:  2007-11-28       Impact factor: 4.246

Review 5.  Ancillary risk information and pharmacogenetic tests: social and policy implications.

Authors:  N B Henrikson; W Burke; D L Veenstra
Journal:  Pharmacogenomics J       Date:  2007-05-08       Impact factor: 3.550

6.  An ethical and legal overview of pharmacogenomics: perspectives and issues.

Authors:  Guillaume Sillon; Yann Joly; Sabrina Feldman; Denise Avard
Journal:  Med Law       Date:  2008-12

7.  Ethical aspects of respiratory research in infancy and early childhood.

Authors:  C S Beardsmore
Journal:  Pediatr Pulmonol       Date:  1998-07

8.  On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease.

Authors:  Allen D Roses
Journal:  J Alzheimers Dis       Date:  2006       Impact factor: 4.472

9.  Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children.

Authors:  Colin J D Ross; Bruce Carleton; Dana G Warn; Sunita B Stenton; Shahrad Rod Rassekh; Michael R Hayden
Journal:  Ann N Y Acad Sci       Date:  2007-09       Impact factor: 5.691

10.  Pharmacogenomics and its implications for autoimmune disease.

Authors:  Colin J D Ross; Hagit Katzov; Bruce Carleton; Michael R Hayden
Journal:  J Autoimmun       Date:  2007-04-05       Impact factor: 7.094
View more
  1 in total

1.  Researchers' perceptions of the ethical implications of pharmacogenomics research with children.

Authors:  D Avard; T Silverstein; G Sillon; Y Joly
Journal:  Public Health Genomics       Date:  2009-02-10       Impact factor: 2.000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.